grant

Outcomes study for the XL1 distraction enterogenesis device to improve nutrient absorption in short bowel syndrome patients

Organization ECLIPSE ENTEROGENESIS, INC.Location MENLO PARK, UNITED STATESPosted 12 Jul 2021Deadline 31 Aug 2028
NIHUS FederalResearch GrantFY20250-11 years old21+ years oldAbscissionAccelerationAdoptionAdultAdult HumanAgeAreaBody TissuesBostonCancersCessation of lifeCharacteristicsChildChild YouthChildhoodChildren (0-21)Children's HospitalChronicClimactericClinicClinicalClinical EvaluationClinical ResearchClinical StudyClinical TestingCrohn diseaseCrohn'sCrohn's diseaseCrohn's disorderData BasesData SetDatabasesDeathDeath RateDefectDependenceDevicesDiagnosisDiseaseDisorderDrugsExcisionExtirpationFailureFamilyFoodFosteringFoundationsGeneralized GrowthGeographyGranulomatous EnteritisGrowthHealth Care CostsHealth CostsHepatic FailureHospital AdmissionHospitalizationImplantInfectionInfrastructureInternationalIntestinalIntestinal AtresiaIntestinal VolvulusIntestine VolvulusIntestinesIntravenousIntravenous FeedingIntravenous HyperalimentationIschemic Bowel DiseaseLengthLifeLiver FailureMalignant NeoplasmsMalignant TumorMedicalMedical DeviceMedicationMidgutNecrotizing EnterocolitisNutrientNutritionOrphanOutcomeOutcome StudyParenteral FeedingsParenteral NutritionPathway interactionsPatientsPediatric HospitalsPharmaceutical PreparationsPhasePopulationProbabilityProceduresProcessProviderRegulatory approvalRemovalReportingResidualResidual stateRiskSafetySecureSepsisSeveritiesShort Bowel SyndromeSiteSmall IntestinesSpeedStretchingSurfaceSurgical RemovalSystemTissue GrowthTissuesTraumaTreatment CostVitaminsVolvulusWeaningWeightWorkabsorptionadulthoodagesbiomedical implantbowelchild patientsclinical testcohortcostcost effectivecurative interventioncurative therapeuticcurative therapycurative treatmentsdata basedistractiondrug/agenteleocolitisfirst in manfirst-in-humanfood Ingestionfood consumptionhyperalimentationhyperalimentation therapyileumimplant deviceimplantable deviceimprovedimproved outcomeindwelling deviceintestinal ischemiaintestine surgeryjejunumkidslife changemalignancymechanical devicemortalitymortality ratemortality rationeoplasm/cancernovelnutrient absorptionontogenypathwaypatient populationpatient retentionpediatricpediatric patientsregional enteritisregulatory authorizationregulatory certificationregulatory clearanceresearch clinical testingresectionrestorative treatmentsafety studysexshort gut syndromeside effectsmall boweltrial designweightsyoungster
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

PROJECT SUMMARY
Short Bowel Syndrome (SBS) is a rare and devastating condition where patients are unable to absorb enough

nutrients naturally to sustain life. SBS results when certain diseases or conditions that destroy the small intestine

force the loss and surgical removal of the majority of the small intestine. In the pediatric patient…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Outcomes study for the XL1 distraction enterogenesis device to improve nutrient absorption in short bowel syndrome patie | Dev Procure